MedTrace Logo

Chest Shielding in Premature Infants During Phototherapy

NCT02552927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-09-18

No results posted yet for this study

Summary

This is a feasibility study where Infants will be randomized to either chest shielding with aluminum foil or chest shielding without aluminum foil while undergoing phototherapy for premature infants. The primary outcome is patent ductus arteriosus.

Conditions

  • Patent Ductus Arteriosus in Premature Infants

Interventions

DEVICE

Chest shield with aluminum foil (CALF)

DEVICE

SHIELD

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Javed Mannan, MD, MPH · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
23 Weeks
Max Age
33 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-01
Primary Completion
2019-02-13
Completion
2019-02-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02552927 on ClinicalTrials.gov